Description
2026 SUBCONTRACTING PLAN EFFECTIVE JANUARY 1, 2026 THROUGH DECEMBER 31, 2026 FOR CLOZAPINE TABLETS WITH MYLAN PHARMACEUTICALS.
Base award description: NEW AWARD FOR CLOZAPINE TABLETS WITH MYLAN. ORDERING PERIOD IS MARCH 4, 2023 TO MARCH 3, 2024 WITH FOUR ONE-YEAR OPTIONS
Modification chain · 9 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-02-02+$0= $0
- Mod P000012023-04-14+$0= $0
- Mod P000022023-11-16+$0= $0
- Mod P000032024-01-29+$0= $0
- Mod P000042024-02-15+$0= $0
- Mod P000052024-12-18+$0= $0
- Mod P000062025-01-24+$0= $0
- Mod P000072025-12-18+$0= $0
- Mod P000082025-12-31+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-02-02 | +$0 | $0 | NEW AWARD FOR CLOZAPINE TABLETS WITH MYLAN. ORDERING PERIOD IS MARCH 4, 2023 TO MARCH 3, 2024 WITH FOUR ONE-YE… |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2023-04-14 | +$0 | $0 | INCORPORATING DSCSA FOR CLOZAPINE TABLETS WITH MYLAN PHARMACEUTICALS, INC. EFFECTIVE 5/15/2023. |
| Mod P00002· ADD SUBCONTRACTING PLAN | 2023-11-16 | +$0 | $0 | INCORPORATING 2024 SUBCONTRACTING PLAN FOR CLOZAPINE TABLETS WITH MYLAN PHARMACEUTICALS, INC. EFFECTIVE 1/1/20… |
| Mod P00003· EXERCISE AN OPTION | 2024-01-29 | +$0 | $0 | EXERCISE OPTION YEAR 1 EFFECTIVE MARCH 4, 2024 THROUGH MARCH 3, 2025 FOR CLOZAPINE TABLETS WITH MYLAN PHARMACE… |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-02-15 | +$0 | $0 | CHANGE IN COST RECOVERY FEE SUBMITTAL AND SALES REPORTING PROCEDURES |
| Mod P00005· ADD SUBCONTRACTING PLAN | 2024-12-18 | +$0 | $0 | 2025 SUBCONTRACTING PLAN |
| Mod P00006· EXERCISE AN OPTION | 2025-01-24 | +$0 | $0 | EXERCISE OPTION YEAR 2 EFFECTIVE MARCH 4, 2025 THROUGH MARCH 3, 2026 FOR CLOZAPINE TABLETS WITH MYLAN PHARMACE… |
| Mod P00007· EXERCISE AN OPTION | 2025-12-18 | +$0 | $0 | EXERCISE OPTION YEAR 3 EFFECTIVE MARCH 4, 2026 THROUGH MARCH 3, 2027 FOR CLOZAPINE TABLETS WITH MYLAN PHARMACE… |
| Mod P00008· ADD SUBCONTRACTING PLAN | 2025-12-31 | +$0 | $0 | 2026 SUBCONTRACTING PLAN EFFECTIVE JANUARY 1, 2026 THROUGH DECEMBER 31, 2026 FOR CLOZAPINE TABLETS WITH MYLAN… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NDN1MYB8DKK5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726D0033 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79725D0054 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36F79723D0025 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79722D0014 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| 36E79721N0050 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
| 36E79721N0043 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $116,444 | FY2021 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79723D0015_3600 · retrieved 2026-09-26.